This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Colombo, B. Articles by Corti, A. Search for Related Content PubMed PubMed Citation Articles by Colombo, B. Articles by Corti, A.

Chromogranin A Expression in Neoplastic Cells Affects Tumor Growth and Morphogenesis in Mouse Models¹

Departments of Biological and Technological Research [B. C., A. M., C. F., A. C.], and Histopathology [G. A.], San Raffaele H Scientific Institute, 20132 Milan, Italy

Chromogranin A (CgA), a secretory protein expressed by many neuroendocrine cells, has been recognized as a useful tissue and serum marker of neuroendocrine tumors. To investigate the effect of CgA secretion on neoplastic morphogenesis and progression, we have transfected mouse RMA lymphoma and TS/A adenocarcinoma cells with the cDNA encoding human CgA and selected several CgA-positive (secreting) and CgA-negative (nonsecreting) clones. In both models, the growth rate of CgA-positive clones implanted s.c. in nude mice was slower than that of CgA-negative clones. Histological analysis of each RMA tumor showed that CgA-expression was associated with multinodular growth patterns, whereas CgA-negative tumors appeared more compact and similar to wild-type RMA tumors. Moreover, CgA production was associated with increased tumor necrosis. The number of nodules in each RMA tumor correlated with the serum levels of CgA (n = 40, r = 0.537, P = 0.0004). The reduced growth rate of CgA-positive RMA and TS/A tumors was not related to reduced in vitro proliferation or to changes in cell adhesion and shape, suggesting that the mechanism is indirect and host-mediated. These results suggest that abnormal secretion of CgA by neuroendocrine neoplastic cells could affect neoplastic growth and morphogenesis.

This article has been cited by other articles:

				D. Belloni, S. Scabini, C. Foglieni, L. Veschini, A. Giazzon, B. Colombo, A. Fulgenzi, K. B. Helle, M. E. Ferrero, A. Corti, et al. The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration FASEB J, October 1, 2007; 21(12): 3052 - 3062. [Abstract] [Full Text] [PDF]

				R. Connolly, D. Gates, N. Loh, D. Baban, R. Thakker, B. Johnston, D. McCance, J. Ardill, D. T. O'Connor, L. Taupenot, et al. Cox-2 Promotes Chromogranin A Expression and Bioactivity: Evidence for a Prostaglandin E2-Dependent Mechanism and the Involvement of a Proximal Cyclic Adenosine 5'-Monophosphate-Responsive Element Endocrinology, September 1, 2007; 148(9): 4310 - 4317. [Abstract] [Full Text] [PDF]

				L. B. Koppert, B. P.L. Wijnhoven, H. W. Tilanus, T. Stijnen, H. van Dekken, and W. N. M. Dinjens Neuroendocrine Cells in Barrett's Mucosa and Adenocarcinomas of the Gastroesophageal Junction International Journal of Surgical Pathology, April 1, 2004; 12(2): 117 - 125. [Abstract] [PDF]

				M. L. Malosio, T. Giordano, A. Laslop, and J. Meldolesi Dense-core granules: a specific hallmark of the neuronal/neurosecretory cell phenotype J. Cell Sci., February 15, 2004; 117(5): 743 - 749. [Abstract] [Full Text] [PDF]

				B. Colombo, R. Longhi, C. Marinzi, F. Magni, A. Cattaneo, S. H. Yoo, F. Curnis, and A. Corti Cleavage of Chromogranin A N-terminal Domain by Plasmin Provides a New Mechanism for Regulating Cell Adhesion J. Biol. Chem., November 22, 2002; 277(48): 45911 - 45919. [Abstract] [Full Text] [PDF]